Cardiovascular Diseases

Global Burden of CVDs and Risk Factors 1990-2023

Data from the Global Burden of Disease (GBD) 2023 study showed that cardiovascular diseases (CVDs) remain the leading cause of death and disability worldwide, with their burden continuing to rise since 1990 due to population growth, aging, and changing exposures to harmful risk factors. The GBD study covered 204 countries and territories, and indicated that CVDs accounted for 437 million disability-adjusted life years (DALYs) and 19.2 million deaths in 2023, both substantial increases from 1990. The number of people living with CVD more than doubled over this period, reaching 626 million cases globally. Ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease were the top contributors to CVD burden, with the highest age-standardized DALY rates found in low and low-middle Socio-demographic Index regions. Nearly 80% of the global CVD burden was linked to modifiable risk factors, primarily high blood pressure, unhealthy diets, high LDL cholesterol, and air pollution, while rising rates of obesity, high blood glucose, and low physical activity further exacerbated the problem despite declines in tobacco use. The study concludes that the decades-long increase in CVD burden has been driven by metabolic risks, demographic shifts, and insufficient control of known risk factors, highlighting the urgent need for stronger health system and public health strategies to achieve global targets in reducing CVD. Source: https://www.jacc.org/

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.